With patients as our North Star, we develop innovations that deliver a real impact for patients and their families, with a focus on making these technologies available more broadly.
With three commercially available product portfolios that address specific gaps in treatment and care of stroke and vascular disease, and more programs underway, Imperative Care is committed to rapid innovation across the entire patient journey.
When a blood clot blocks a vital vessel, time is of the essence. Whether it’s within minutes, hours or days, the patient will suffer life-changing damage if the clot isn’t removed quickly. That’s why we’re engineering solutions to give patients the best chance at a full recovery and restored independence.
someone in the United States has a stroke.1
one person dies from a blood clot in the United States.2
We know that the future is dependent on the innovations we invest in today.
Our story began in 2015, when serial medtech entrepreneur Fred Khosravi cofounded Imperative Care with the late L. Nelson (Nick) Hopkins, M.D. F.A.C.S., a pioneering leader in endovascular neurosurgery. After decades of successful partnership, Nick and Fred recognized the clear need for a company to focus on elevating every phase of care across the entire patient journey, and making this care accessible to more people. They founded Imperative Care with a singular focus on stroke, which has since expanded to include other devastating vascular diseases.